The safety of warfarin in cardiac surgery from the standpoint of pharmacogenetics

A comparison of pharmacogenetic and empirical approaches to the selection of warfarin dose in relation to the speed of achieving therapeutic values of the International Normalized Ratio (INR) and its stabilit y has been carried out.

Authors

Raushan Barakanova
Taalaibek Kudaiberdiev (ORCID: https://orcid.org/0000-0002-3669-066X)
U. M. Tilekeeva

Publication Details

Journal: Glavvrač (Chief Medical Officer)
Published: 2025-04-29
DOI: https://doi.org/10.33920/med-03-2505-08
Primary Topic: Cardiac, Anesthesia and Surgical Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The safety of warfarin in cardiac surgery from the standpoint of pharmacogenetics

Raushan Barakanova, Taalaibek Kudaiberdiev, U. M. Tilekeeva

Apr 29, 2025

Glavvrač (Chief Medical Officer)

Cardiac, Anesthesia and Surgical Outcomes

article

The safety of warfarin in cardiac surgery from the standpoint of pharmacogenetics

Raushan Barakanova, Taalaibek Kudaiberdiev, U. M. Tilekeeva

April 29, 2025article en

Abstract

Glavvrač (Chief Medical Officer)(5)

Openalex Percentile: Top 81%

Cardiac, Anesthesia and Surgical Outcomes

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The safety of warfarin in cardiac surgery from the standpoint of pharmacogenetics — Raushan Barakanova, Taalaibek Kudaiberdiev, et al. · Glavvrač (Chief Medical Officer) (2025) | TGRS Research Map | TGRS